88 related articles for article (PubMed ID: 10474832)
1. A comparison of the effects of diverse mutagens at the lacZ transgene and Dlb-1 locus in vivo.
Cosentino L; Heddle JA
Mutagenesis; 1999 Jan; 14(1):113-9. PubMed ID: 10474832
[TBL] [Abstract][Full Text] [Related]
2. The application of the restriction site mutation assay to compare 1-ethyl-1-nitrosourea-induced mutations between the endogenous p53 gene and the transgenic LacZ gene in MutaMouse testes.
Song HL; Jenkins GJ; Ashby J; Tinwell H; Parry JM
Mutagenesis; 2001 Jan; 16(1):59-64. PubMed ID: 11139599
[TBL] [Abstract][Full Text] [Related]
3. Response of the phiX174 am3, cs70 transgene to acute and chronic ENU exposure: implications for protocol design.
Cosentino L; Malling HV; Heddle JA
Mutat Res; 2002 Jul; 518(2):113-21. PubMed ID: 12113762
[TBL] [Abstract][Full Text] [Related]
4. Differential mutation of transgenic and endogenous loci in vivo.
Cosentino L; Heddle JA
Mutat Res; 2000 Nov; 454(1-2):1-10. PubMed ID: 11035154
[TBL] [Abstract][Full Text] [Related]
5. Effects of extended chronic exposures on endogenous and transgenic loci: implications for low-dose extrapolations.
Cosentino L; Heddle JA
Environ Mol Mutagen; 1999; 34(2-3):208-15. PubMed ID: 10529746
[TBL] [Abstract][Full Text] [Related]
6. Gene-mutation assays in lambda lacZ transgenic mice: comparison of lacZ with endogenous genes in splenocytes and small intestinal epithelium.
van Delft JH; Bergmans A; van Dam FJ; Tates AD; Howard L; Winton DJ; Baan RA
Mutat Res; 1998 Jul; 415(1-2):85-96. PubMed ID: 9711265
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the mutational spectra of the lacZ transgene in four organs of the MutaMouse treated with benzo[a]pyrene: target organ specificity.
Hakura A; Tsutsui Y; Sonoda J; Tsukidate K; Mikami T; Sagami F
Mutat Res; 2000 Feb; 447(2):239-47. PubMed ID: 10751607
[TBL] [Abstract][Full Text] [Related]
8. Comparison of somatic mutation in a transgenic versus host locus.
Tao KS; Urlando C; Heddle JA
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10681-5. PubMed ID: 8248160
[TBL] [Abstract][Full Text] [Related]
9. The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicals.
Cox JA; Zwart EP; Luijten M; White PA
Environ Mol Mutagen; 2019 May; 60(4):348-360. PubMed ID: 30714215
[TBL] [Abstract][Full Text] [Related]
10. A test for neutrality of mutations of the lacZ transgene.
Cosentino L; Heddle JA
Environ Mol Mutagen; 1996; 28(4):313-6. PubMed ID: 8991058
[TBL] [Abstract][Full Text] [Related]
11. Further characterization and validation of gpt delta transgenic mice for quantifying somatic mutations in vivo.
Swiger RR; Cosentino L; Masumura KI; Nohmi T; Heddle JA
Environ Mol Mutagen; 2001; 37(4):297-303. PubMed ID: 11424179
[TBL] [Abstract][Full Text] [Related]
12. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
13. Folate deficiency increases chromosomal damage and mutations in hematopoietic cells in the transgenic mutamouse model.
LeBlanc DP; Behan NA; O'Brien JM; Marchetti F; MacFarlane AJ
Environ Mol Mutagen; 2018 Jun; 59(5):366-374. PubMed ID: 29668043
[TBL] [Abstract][Full Text] [Related]
14. A lacZ transgenic mouse assay for the detection of mutations in follicular granulosa cells.
Yauk CL; Gingerich JD; Soper L; MacMahon A; Foster WG; Douglas GR
Mutat Res; 2005 Oct; 578(1-2):117-23. PubMed ID: 16039675
[TBL] [Abstract][Full Text] [Related]
15. Induction of lacZ mutations in MutaMouse primary hepatocytes.
Chen G; Gingerich J; Soper L; Douglas GR; White PA
Environ Mol Mutagen; 2010 May; 51(4):330-7. PubMed ID: 19953605
[TBL] [Abstract][Full Text] [Related]
16. The cII locus in the MutaMouse system.
Swiger RR; Cosentino L; Shima N; Bielas JH; Cruz-Munoz W; Heddle JA
Environ Mol Mutagen; 1999; 34(2-3):201-7. PubMed ID: 10529745
[TBL] [Abstract][Full Text] [Related]
17. Benzo(a)pyrene Is Mutagenic in Mouse Spermatogonial Stem Cells and Dividing Spermatogonia.
O'Brien JM; Beal MA; Yauk CL; Marchetti F
Toxicol Sci; 2016 Aug; 152(2):363-71. PubMed ID: 27208087
[TBL] [Abstract][Full Text] [Related]
18. Formation and persistence of O6-ethylguanine in genomic and transgene DNA in liver and brain of lambda(lacZ) transgenic mice treated with N-ethyl-N-nitrosourea.
Mientjes EJ; Hochleitner K; Luiten-Schuite A; van Delft JH; Thomale J; Berends F; Rajewsky MF; Lohman PH; Baan RA
Carcinogenesis; 1996 Nov; 17(11):2449-54. PubMed ID: 8968062
[TBL] [Abstract][Full Text] [Related]
19. Benzo[a]pyrene site of contact mutagenicity in skin of Muta Mouse.
Dean SW; Coates A; Brooks TM; Burlinson B
Mutagenesis; 1998 Sep; 13(5):515-8. PubMed ID: 9800197
[TBL] [Abstract][Full Text] [Related]
20. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]